Clearance and Safety of the Radiocontrast Medium Iopamidol in Peritoneal Dialysis Patients

Table 3

Adverse events and residual renal function after angiographic CT scans. The incidence of adverse events, Crea, eGFR, and urine volume for 3 months after angiographic CT scans is shown. Two patients showed adverse events within one day, in immediate HD group. No adverse event was observed in non-HD group. Crea, eGFR, and urine volume were not different before and after angiographic CT scans. Statistical analysis in non-HD group was compared to baseline, 1, 2, and 3 months (paired 𝑡test).

non-HD	RRF (+)	Crea	eGFR	Urine vol.	RRF (−)	Crea	eGFR	Urine vol.
𝑛	16				28
Angiographic CT (times)	19				39
Adverse event	0				0
Baseline		11.8±6.4	4.97±2.47	442±424		11.2±2.56	4.23±1.00	6.77±29.3
1 month		11.5±4.3	5.23±3.35	451±387		11.1±2.53	4.28±0.96	11.6±50.9
2 months		11.3±3.7	4.85±2.44	415±345		11.0±2.26	4.27±0.88	3.71±16.7
3 months		11.3±3.7	4.93±2.51	414±360		10.9±2.30	4.33±0.96	8.67±35.5
𝑃 value		n.s.	n.s.	n.s.		n.s.	n.s.	n.s.
Immediate HD	RRF (+)	Crea	eGFR	Urine vol.	RRF (−)	Crea	eGFR	Urine vol.
𝑛	2				4
Angiographic CT (times)	2				4
Adverse event	1				1
Baseline		11.1±1.60	4.47±0.35	275±95.7		11.6±2.90	3.83±0.77	12.5±28.0
1 month		12.9±4.60	3.97±1.15	175±177		11.8±3.88	3.78±1.00	17.5±28.7
2 months		12.2±3.96	4.15±1.05	150±70.7		11.9±2.37	3.60±0.37	5.25±6.08
3 months		12.5±4.10	4.04±1.04	300±141		12.3±2.09	3.45±0.42	6.25±7.50